BioWarn Announces Instantaneous Detection Of Avian Flu With SmartSense™ System: Receives Approval Of Patent Issuance

BioWarn, LLC, a biotechnology research and product development company, announced today that it has successfully demonstrated the capability to instantaneously detect avian influenza (H5N1), also known as bird flu, using its new SmartSense system for the detection of biological substances.

Back to news